Open AccessRole of the ACTH test and estimation of a safe dose for high potency steroids in vitiligo: A prospective randomized study
Author(s) -
Alberto de la Fuente-García,
Minerva GómezFlores,
Leonardo Mancillas-Adame,
Jorge OcampoCandiani,
Oliverio WelshLozano,
Jesús Zacarías Villarreal Pérez,
José Gerardo González-González,
Fernando Javier Lavalle-González
Publication year - 2014
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/2229-5178.131071
Subject(s) - medicine , vitiligo , potency , placebo , clobetasol propionate , side effect (computer science) , randomized controlled trial , corticosteroid , dermatology , statistical significance , body surface area , adrenal insufficiency , urology , pathology , biochemistry , chemistry , alternative medicine , computer science , in vitro , programming language
Topical corticosteroids are used as first line of therapy for vitiligo, although side effects such as adrenal insufficiency are possible.